IDEXX Labs (IDXX) Tops Q3 EPS by 8c; offers guidance

IDEXX Labs (NASDAQ: IDXX) reported Q3 EPS of $3.22, $0.08 better than the analyst estimate of $3.14. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.07 billion.

GUIDANCE:

IDEXX Labs sees FY2025 EPS of $12.81-$13.01, versus the consensus of $12.63. IDEXX Labs sees FY2025 revenue of $4.27-4.3 billion, versus the consensus of $4.235 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• ADARx Pharmaceuticals files for proposed IPO
• Epic Gold plans $3.15M non-brokered private placement